Three-month outcomes of faricimab loading therapy for wet age-related macular degeneration in Japan

Three-month outcomes of faricimab loading therapy for wet age-related macular degeneration in Japan

Abstract This multicenter study aimed to assess the short-term effectiveness and safety of faricimab in treatment-naïve patients with wet age-related macular degeneration (wAMD) in Japan. We retrospectively reviewed 63 eyes of 61 patients with wAMD, including types 1, 2, and 3 macular neovasculariza...

Full description

Bibliographic Details
Main Authors:	Ryo Mukai, Keiko Kataoka, Koji Tanaka, Yasunori Miyara, Ichiro Maruko, Makiko Nakayama, Yuto Watanabe, Akiko Yamamoto, Yu Wakatsuki, Hajime Onoe, Sorako Wakugawa, Nobuhiro Terao, Taiji Hasegawa, Nozomu Hashiya, Moeko Kawai, Ruka Maruko, Kanako Itagaki, Jyunichiro Honjo, Annabelle A. Okada, Ryusaburo Mori, Hideki Koizumi, Tomohiro Iida, Tetsuju Sekiryu
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-05-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-023-35759-4

Similar Items

One-year outcomes and safety assessment of faricimab in treatment-naïve patients with neovascular age-related macular degeneration in Japan
by: Ryo Mukai, et al.
Published: (2024-05-01)

Exploring the comparative regressive effects of aflibercept and faricimab on pigment epithelial detachment
by: Ryo Mukai, et al.
Published: (2024-09-01)

Intraocular inflammation after intravitreal injection of aflibercept 8 mg for treatment-refractory neovascular age-related macular degeneration: a case report
by: Nozomu Hashiya, et al.
Published: (2025-01-01)

Blood flow pattern in eye before development of type 3 macular neovascularization.
by: Saya Yamaguchi, et al.
Published: (2023-01-01)

Pachychoroid neovasculopathy has clinical properties that differ from conventional neovascular age-related macular degeneration
by: Ai Kuranami, et al.
Published: (2023-05-01)

Long-term characteristics of exudative age-related macular degeneration in Japanese patients.
by: Masaaki Saito, et al.
Published: (2021-01-01)

Fundus Autofluorescence and Optical Coherence Tomography Findings in Branch Retinal Vein Occlusion
by: Tetsuju Sekiryu, et al.
Published: (2012-01-01)

Diagnosis of central serous chorioretinopathy by deep learning analysis of en face images of choroidal vasculature: A pilot study.
by: Yukihiro Aoyama, et al.
Published: (2021-01-01)

Fundus autofluorescence of retinal angiomatous proliferation.
by: Masaaki Saito, et al.
Published: (2020-01-01)

Foveal structure and vasculature in eyes with idiopathic epiretinal membrane.
by: Yuka Okawa, et al.
Published: (2019-01-01)

Subthreshold 577 nm micropulse laser treatment for central serous chorioretinopathy.
by: Ichiro Maruko, et al.
Published: (2017-01-01)

Long-term prognostic factors of chronic central serous chorioretinopathy after half-dose photodynamic therapy: A 3-year follow-up study.
by: Fuminori Haga, et al.
Published: (2017-01-01)

Misalignment of center of foveal avascular zone and center of photoreceptors in eyes with history of retinopathy of prematurity
by: Ichiro Maruko, et al.
Published: (2024-01-01)

Acute idiopathic maculopathy after COVID-19 vaccination
by: Taiji Hasegawa, et al.
Published: (2022-06-01)

Visualizing large choroidal blood flow by subtraction of the choriocapillaris projection artifacts in swept source optical coherence tomography angiography in normal eyes
by: Ichiro Maruko, et al.
Published: (2018-10-01)

The characteristics of choriocapillaris flow void in the unilateral polypoidal choroidal vasculopathy fellow eyes
by: Huajui Wu, et al.
Published: (2021-11-01)

Faricimab for Treatment-Resistant Diabetic Macular Edema
by: Rush RB, et al.
Published: (2022-08-01)

Age-Dependent Morphologic Alterations in the Outer Retinal and Choroidal Thicknesses Using Swept Source Optical Coherence Tomography.
by: Ichiro Maruko, et al.
Published: (2016-01-01)

Bilateral Serous Retinal Detachment Associated with Inferior Posterior Staphyloma Treated with Scleral Shortening and Vitrectomy
by: Akihito Kasai, et al.
Published: (2016-05-01)

Scleral Thickness in Steroid-Induced Central Serous Chorioretinopathy
by: Shota Sawaguchi, MD, et al.
Published: (2022-06-01)

Short Axial Length Is Related to Asymmetric Vortex Veins in Central Serous Chorioretinopathy
by: Nobuhiro Terao, MD, PhD, et al.
Published: (2021-12-01)

Occlusive retinal vasculitis associated with intravitreal Faricimab injections
by: Reichel, FF, et al.
Published: (2024)

Occlusive retinal vasculitis associated with intravitreal Faricimab injections
by: Felix F. Reichel, et al.
Published: (2024-09-01)

Dynamics of Treatment Response to Faricimab for Diabetic Macular Edema
by: Katrin Fasler, et al.
Published: (2024-09-01)

Dissecting the daily feeding pattern: Peripheral CLOCK/CYCLE generate the feeding/fasting episodes and neuronal molecular clocks synchronize them
by: Akiko Maruko, et al.
Published: (2023-11-01)

Effects of switching from intravitreal injection of aflibercept to faricimab on ocular blood flow in patients with diabetic macular edema
by: Yoshinari Saima, et al.
Published: (2024-06-01)

Human Factors Studies to Assess the Usability of the Faricimab Prefilled Syringe
by: Barakat MR, et al.
Published: (2025-02-01)

Faricimab for Diabetic Macular Edema in Patients Refractory to Ranibizumab or Aflibercept
by: Hiromi Ohara, et al.
Published: (2023-06-01)

Impact of Topically Administered Steroids, Antibiotics, and Sodium Hyaluronate on Bleb-Related Infection Onset: The Japan Glaucoma Society Survey of Bleb-Related Infection Report 4
by: Hideto Sagara, et al.
Published: (2017-01-01)

Comparison of clinical findings and subjective symptoms in a case of multiple evanescent white dot syndrome (MEWDS): A case report from a patient's perspective
by: Kotaro Sugimoto, et al.
Published: (2024-05-01)

Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration
by: Hang A, et al.
Published: (2024-12-01)

Therapeutic effects of faricimab on aflibercept-refractory age-related macular degeneration
by: Ryosuke Tamiya, et al.
Published: (2023-11-01)

Short-Term Outcomes of Intravitreal Faricimab Injection for Diabetic Macular Edema
by: Sentaro Kusuhara, et al.
Published: (2023-03-01)

Intravitreal Faricimab for Aflibercept-Resistant Neovascular Age-Related Macular Degeneration
by: Rush RB, et al.
Published: (2022-12-01)

One Year Results of Faricimab for Aflibercept-Resistant Diabetic Macular Edema
by: Rush RB
Published: (2023-08-01)

Estimation of foveal avascular zone area from a B-scan OCT image using machine learning algorithms.
by: Taku Toyama, et al.
Published: (2024-01-01)

Estimation of foveal avascular zone area from a B-scan OCT image using machine learning algorithms
by: Taku Toyama, et al.
Published: (2024-01-01)

Choroidal atrophy in a patient with paraneoplastic retinopathy and anti-TRPM1 antibody
by: Ueno S, et al.
Published: (2014-02-01)

Optimization of individualized faricimab dosing for patients with diabetic macular edema: Protocol for the SWAN open-label, single-arm clinical trial.
by: Takao Hirano, et al.
Published: (2024-01-01)

One-year visual and anatomical outcomes of intravitreal faricimab injection for neovascular age-related macular degeneration after prior brolucizumab treatment
by: Hironori Takahashi, et al.
Published: (2024-04-01)